World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
40958
World Ranking
11128
National Ranking
5727

Gerald B. Appel publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gerald B. Appel sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 288 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gerald B. Appel D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gerald B. Appel sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Gerald B. Appel is affiliated with Columbia University in the United States and works primarily in the field of medicine, with a focus on nephrology. Their research interests span several subfields including genetics, molecular biology, immunology, and hematology. The main topics covered in their work include renal diseases and glomerulopathies, chronic kidney disease and diabetes, the complement system in diseases, platelet disorders and treatments, vasculitis and related conditions, cell adhesion molecules research, as well as renal and related cancers.

Their recent publications demonstrate a broad engagement with kidney-related research and its underlying molecular and genetic mechanisms. Notable papers include:

  • The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis (2020, Nature Communications)
  • Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial (2023, The Lancet)
  • Development and evaluation of deep learning-based segmentation of histologic structures in the kidney cortex with multiple histologic stains (2020, Kidney International)
  • Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy (2023, Nature Genetics)
  • A meta-analysis of GFR slope as a surrogate endpoint for kidney failure (2023, Nature Medicine)

Gerald B. Appel collaborates frequently with several researchers, including:

  • Andrew S. Bomback
  • Pietro A. Canetta
  • Jai Radhakrishnan
  • Maddalena Marasà
  • Fernando C. Fervenza

Their work has been published in multiple venues, reflecting a deep engagement with nephrology and kidney health research. Key publication venues where they have contributed extensively include:

  • Journal of the American Society of Nephrology
  • Kidney International Reports
  • Clinical Journal of the American Society of Nephrology
  • Kidney International
  • American Journal of Kidney Diseases

Best Publications

  • The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited

    Jan J. Weening;Vivette D. D'Agati;Melvin M. Schwartz;Surya V. Seshan

  • Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study†

    Brad H. Rovin;Richard Furie;Kevin Latinis;R. John Looney

  • Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

    Ellen M. Ginzler;Mary Anne Dooley;Cynthia Aranow;Mimi Y. Kim

  • Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

    Gerald B. Appel;Gabriel Contreras;Mary Anne Dooley;Ellen M. Ginzler

  • Diagnostic Utility of Exome Sequencing for Kidney Disease

    Emily E Groopman;Maddalena Marasa;Sophia Cameron-Christie;Slavé Petrovski

  • Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis

    Mary Anne Dooley;David Jayne;Ellen M. Ginzler;David Isenberg

  • Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

  • C3 glomerulopathy: consensus report

    Matthew C. Pickering;Vivette D. D'agati;Carla M. Nester;Richard J. Smith

  • Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens

    Krzysztof Kiryluk;Yifu Li;Francesco Scolari;Simone Sanna-Cherchi

  • Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy

    W. Kline Bolton;Daniel C. Cattran;Mark E. Williams;Sharon G. Adler

  • Collapsing Focal Segmental Glomerulosclerosis Following Treatment with High-Dose Pamidronate

    Glen S. Markowitz;Gerald B. Appel;Paul L. Fine;Andrew Z. Fenves

  • Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study.

    Vivette D'Agati;Jung-Il Suh;Laura Carbone;Jen-Tse Cheng

  • Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease): An Update

    Gerald B. Appel;H. Terence Cook;Gregory Hageman;J. Charles Jennette

  • Renal monoclonal immunoglobulin deposition disease : The disease spectrum

    Julie Lin;Glen S. Markowitz;Anthony M. Valeri;Neeraja Kambham

  • Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.

    Daniel C. Cattran;Gerald B. Appel;Lee A. Hebert;Lawrence G. Hunsicker

  • Adult Minimal-Change Disease: Clinical Characteristics, Treatment, and Outcomes

    Meryl Waldman;R. John Crew;Anthony Valeri;Joshua Busch

  • Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

    Fernando C. Fervenza;Gerald B. Appel;Sean J. Barbour;Brad H. Rovin

  • Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis

    Andrew S. Bomback;Richard J. Smith;Gaetano R. Barile;Yuzhou Zhang

  • Proliferative Glomerulonephritis with Monoclonal IgG Deposits

    Samih H. Nasr;Anjali Satoskar;Glen S. Markowitz;Anthony M. Valeri

  • ATYPICAL HEMOLYTIC UREMIC SYNDROME AND C3 GLOMERULOPATHY: CONCLUSIONS FROM A «KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES» (KDIGO) CONTROVERSIES CONFERENCE

    Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

Frequent Co-Authors

Vivette D. D'Agati
Vivette D. D'Agati Columbia University
Glen S. Markowitz
Glen S. Markowitz Columbia University
Harold C. Neu
Harold C. Neu Columbia University
Martin R. Pollak
Martin R. Pollak Beth Israel Deaconess Medical Center
Daniel C. Cattran
Daniel C. Cattran University Health Network
Ali G. Gharavi
Ali G. Gharavi Columbia University
Ellen M. Ginzler
Ellen M. Ginzler SUNY Downstate Medical Center
Lawrence B. Holzman
Lawrence B. Holzman University of Pennsylvania
J. Charles Jennette
J. Charles Jennette University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in studying Medicine in the USA, there are several online education and career pathways to consider. These options offer flexibility, financial aid, and avenues for professional growth within the healthcare field.

For students looking to start quickly in the healthcare industry, medical billing and coding schools with financial aid provide a fast track into administrative and information management roles. These programs are ideal for those seeking a shorter and more affordable entry point.

Aspiring nurses can also find a nursing school that does not require teas test, eliminating one of the major barriers to application. This makes pursuing a nursing degree more accessible to a wider range of students.

Those interested in leadership roles within healthcare can explore a healthcare administration online degree, which provides skills for managing hospitals, clinics, and other healthcare organizations.

Already an RN? Accelerate your career growth through an rn to np bridge program, helping you transition into advanced clinical roles as a nurse practitioner.

Best Scientists Citing Gerald B. Appel

Trending Scientists

Recently Published Articles